RECURSION PHARMACEUTICALS-A (RXRX) Stock Analyst Ratings
NASDAQ:RXRX - Nasdaq - US75629V1044 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 73% to RXRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.33. This target is 11.82% above the current price.
RXRX was analyzed by 14 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about RXRX.
In the previous month the buy percentage consensus was at a similar level.
RXRX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-06 | Needham | Reiterate | Buy -> Buy |
| 2025-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-12-11 | Needham | Reiterate | Buy -> Buy |
| 2024-11-20 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-09-04 | Needham | Maintains | Buy -> Buy |
| 2024-09-03 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2024-09-03 | Jefferies | Maintains | Hold -> Hold |
| 2024-08-09 | Needham | Maintains | Buy -> Buy |
| 2024-07-11 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-06-25 | Needham | Reiterate | Buy -> Buy |
| 2024-05-10 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-04 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-01-26 | TD Cowen | Initiate | Market Perform |
| 2024-01-17 | Needham | Reiterate | Buy -> Buy |
| 2024-01-16 | Needham | Reiterate | Buy -> Buy |
| 2023-11-13 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-11-09 | Needham | Maintains | Buy -> Buy |
| 2023-09-05 | Needham | Reiterate | Buy -> Buy |
| 2023-08-09 | Needham | Reiterate | Buy -> Buy |
| 2023-07-21 | Needham | Reiterate | Buy -> Buy |
| 2023-07-18 | Needham | Reiterate | Buy -> Buy |
| 2023-07-13 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-07-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-12 | Berenberg | Reiterate | Buy -> Buy |
| 2023-07-12 | Needham | Reiterate | Buy -> Buy |
| 2023-05-09 | Needham | Reiterate | Buy |
| 2023-05-09 | Keybanc | Maintains | Overweight |